| Product NDC: | 0088-1209 |
| Proprietary Name: | Anzemet |
| Non Proprietary Name: | dolasetron mesylate |
| Active Ingredient(s): | 500 mg/25mL & nbsp; dolasetron mesylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0088-1209 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020624 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970911 |
| Package NDC: | 0088-1209-26 |
| Package Description: | 25 mL in 1 VIAL, MULTI-DOSE (0088-1209-26) |
| NDC Code | 0088-1209-26 |
| Proprietary Name | Anzemet |
| Package Description | 25 mL in 1 VIAL, MULTI-DOSE (0088-1209-26) |
| Product NDC | 0088-1209 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dolasetron mesylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19970911 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DOLASETRON MESYLATE |
| Strength Number | 500 |
| Strength Unit | mg/25mL |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |